Viktor Kharitonin
Place
-
Now26th
-
Last week26th
-
Two weeks ago26th
-
Three weeks ago28th
- Name
- Viktor Kharitonin
- Net Worth
- 6.9 Billion USD
- Birth Date
- 20 November 1972
- Age
- 51
- Country
- Russia
- City
- Moscow
- Business
- Healthcare
Viktor Kharitonin, a prominent Russian billionaire, has made significant contributions to the pharmaceutical industry and healthcare sector through his entrepreneurial endeavors and strategic investments. Born in 1972, Kharitonin is the co-founder and chairman of Pharmstandard, one of Russia's leading pharmaceutical companies.
Under Kharitonin's leadership, Pharmstandard has grown into a diversified healthcare conglomerate, specializing in the production of pharmaceuticals, medical devices, and dietary supplements. The company's portfolio includes a wide range of therapeutic products that address various medical conditions, contributing to the improvement of public health in Russia and beyond.
Beyond his role at Pharmstandard, Viktor Kharitonin is actively involved in promoting innovation and research in the pharmaceutical field. He has supported initiatives aimed at developing new drugs and treatments, fostering partnerships with leading research institutions and healthcare organizations globally.
Kharitonin's entrepreneurial success extends beyond pharmaceuticals. He has diversified his investments into other sectors, including real estate and technology, leveraging his business acumen to identify opportunities for growth and expansion.
As a philanthropist, Viktor Kharitonin is committed to supporting social causes and community development in Russia. Through the Kharitonin Foundation, he has contributed to charitable programs focused on education, healthcare, and cultural initiatives, aiming to create positive social impact and improve quality of life.
Viktor Kharitonin's entrepreneurial spirit, coupled with his dedication to healthcare innovation and philanthropy, underscores his significant influence in Russia's business community and healthcare sector. His leadership continues to drive growth and advancement in pharmaceuticals and contribute to societal welfare through impactful philanthropic initiatives.
Share
Your involvement